Advance Search
CHEN Mingyuan, JIANG Yan. Research progress on prevention and management of complications associated with hyaluronic acid injectable fillers[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 138-143. DOI: 10.7619/jcmp.20245900
Citation: CHEN Mingyuan, JIANG Yan. Research progress on prevention and management of complications associated with hyaluronic acid injectable fillers[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 138-143. DOI: 10.7619/jcmp.20245900
shu

Research progress on prevention and management of complications associated with hyaluronic acid injectable fillers

  • 1.

    Graduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, 310053

  • 2.

    Medical Cosmetology Department, Maternity and Child Healthcare Hospital of Shaoxing City of Zhejiang Province, Shaoxing, Zhejiang, 312000

More Information
  • Received Date: November 28, 2024
  • Revised Date: January 12, 2025
    Graphical Abstract
    • Abstract

  • This study retrospectively analyzed the literature on the prevention and management of complications associated with hyaluronic acid injectable fillers. Starting with the physicochemical properties and pharmacological research of hyaluronic acid, this review summarized its clinical application in facial injection, complications, and corresponding treatment modalities. Clinicians administering hyaluronic acid injections should attach great importance to potential risks, adopt targeted preventive measures, and promptly address issues to maximize the avoidance of severe complications.

    • FullText(HTML)
    • References (61)
  • [1]
    MEYER K, PALMER J W. The polysaccride of vitreous humor[J]. J Biol Chem, 1934, 107: 629-634. doi: 10.1016/S0021-9258(18)75338-6
    [2]
    YAMAMOTO T, RANDRIANTSILEFISOA R, SPRECHER C M, et al. Fabrication of collagen-hyaluronic acid cryogels by directional freezing mimicking cartilage arcade-like structure[J]. Biomolecules, 2022, 12(12): 1809. doi: 10.3390/biom12121809
    [3]
    LA GATTA A, DE ROSA M, FREZZA M A, et al. Biophysical and biological characterization of a new line of hyaluronan-based dermal fillers: a scientific rationale to specific clinical indications[J]. Mater Sci Eng C Mater Biol Appl, 2016, 68: 565-572. doi: 10.1016/j.msec.2016.06.008
    [4]
    GALL Y. Hyaluronic acid: structure, metabolism and implication in cicatrisation[J]. Ann Dermatol Venereol, 2010, 137(Suppl 1): S30-S39.
    [5]
    OLIVA F, MARSILIO E, ASPARAGO G, et al. The impact of hyaluronic acid on tendon physiology and its clinical application in tendinopathies[J]. Cells, 2021, 10(11): 3081. doi: 10.3390/cells10113081
    [6]
    CAVALLINI M, GAZZOLA R, METALLA M, et al. The role of hyaluronidase in the treatment of complications from hyaluronic acid dermal fillers[J]. Aesthet Surg J, 2013, 33(8): 1167-1174. doi: 10.1177/1090820X13511970
    [7]
    YAMAMOTO A, SHIMIZU N, KUROYANAGI Y. Potential of wound dressing composed of hyaluronic acid containing epidermal growth factor to enhance cytokine production by fibroblasts[J]. J Artif Organs, 2013, 16(4): 489-494. doi: 10.1007/s10047-013-0726-0
    [8]
    麻凤玉, 吴彬, 章旭, 等. 不同浓度透明质酸水凝胶对骨形态发生蛋白2基因修饰的BMSCs特性的影响[J]. 济宁医学院学报, 2017, 40(2): 87-92.
    [9]
    CHEN R F, WANG C T, CHEN Y H, et al. Hyaluronic acid-povidone-iodine compound facilitates diabetic wound healing in a streptozotocin-induced diabetes rodent model[J]. Plast Reconstr Surg, 2019, 143(5): 1371-1382. doi: 10.1097/PRS.0000000000005504
    [10]
    张堃, 简军, 张政朴. 透明质酸的结构、性能、改性和应用研究进展[J]. 高分子通报, 2015(9): 217-226.
    [11]
    ALVAREZ O M, MAKOWITZ L, PATEL M. Venous ulcers treated with a hyaluronic acid extracellular matrix and compression therapy: interim analysis of a randomized controlled trial[J]. Wounds, 2017, 29(7): E51-E54.
    [12]
    TOKATLIAN T, CAM C, SEGURA T. Porous hyaluronic acid hydrogels for localized nonviral DNA delivery in a diabetic wound healing model[J]. Adv Healthc Mater, 2015, 4(7): 1084-1091. doi: 10.1002/adhm.201400783
    [13]
    金艳, 李大伟, 祝美华, 等. 透明质酸在皮肤创伤修复中的应用[J]. 食品与药品, 2014, 16(5): 373-376.
    [14]
    周卫, 刘灿, 孔焕宇, 等. 三七透明质酸钠凝胶对家兔硬膜外瘢痕中Cox-2、TGF-β1及CTGF表达的影响[J]. 中国脊柱脊髓杂志, 2011, 21(5): 384-389.
    [15]
    徐泉, 周卫, 孔焕宇, 等. 三七透明质酸钠凝胶对家兔椎板切除术后硬膜外瘢痕中胶原成分的影响[J]. 中国骨伤, 2010, 23(4): 278-281.
    [16]
    刘灿, 周卫, 孔焕宇, 等. 三七透明质酸钠凝胶对家兔硬膜外瘢痕中成纤维细胞凋亡的影响[J]. 世界中医药, 2010, 5(4): 282-284.
    [17]
    LI L, WANG N, JIN X, et al. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention[J]. Biomaterials, 2014, 35(12): 3903-3917. doi: 10.1016/j.biomaterials.2014.01.050
    [18]
    FAKHARI A, BERKLAND C. Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment[J]. Acta Biomater, 2013, 9(7): 7081-7092. doi: 10.1016/j.actbio.2013.03.005
    [19]
    EDSMAN K, NORD L I, OHRLUND A, et al. Gel properties of hyaluronic acid dermal fillers[J]. Dermatol Surg, 2012, 38(7 Pt 2): 1170-1179.
    [20]
    EDSMAN K L M, ÖHRLUND Å. Cohesion of hyaluronic acid fillers: correlation between cohesion and other physicochemical properties[J]. Dermatol Surg, 2018, 44(4): 557-562. doi: 10.1097/DSS.0000000000001370
    [21]
    KABLIK J, MONHEIT G D, YU L P, et al. Comparative physical properties of hyaluronic acid dermal fillers[J]. Dermatol Surg, 2009, 35(Suppl 1): 302-312.
    [22]
    BORRELL M, LESLIE D, TEZEL A. Response of authors: Lift capabilities of hyaluronic acid fillers[J]. J Cosmet Laser Ther, 2011, 13(4): 200-201. doi: 10.3109/14764172.2011.586427
    [23]
    BASS L S. Injectable filler techniques for facial rejuvenation, volumization, and augmentation[J]. Facial Plast Surg Clin North Am, 2015, 23(4): 479-488. doi: 10.1016/j.fsc.2015.07.004
    [24]
    SAFRAN T, SWIFT A, COTOFANA S, et al. Evaluating safety in hyaluronic acid lip injections[J]. Expert Opin Drug Saf, 2021, 20(12): 1473-1486. doi: 10.1080/14740338.2021.1962283
    [25]
    URDIALES-GÁLVEZ F, DELGADO N E, FIGUEIREDO V, et al. Treatment of soft tissue filler complications: expert consensus recommendations[J]. Aesthetic Plast Surg, 2018, 42(2): 498-510. doi: 10.1007/s00266-017-1063-0
    [26]
    URDIALES-GÁLVEZ F, DELGADO N E, FIGUEIREDO V, et al. Preventing the complications associated with the use of dermal fillers in facial aesthetic procedures: an expert group consensus report[J]. Aesthetic Plast Surg, 2017, 41(3): 667-677.
    [27]
    CHIANG Y Z, PIERONE G, AL-NIAIMI F. Dermal fillers: pathophysiology, prevention and treatment of complications[J]. J Eur Acad Dermatol Venereol, 2017, 31(3): 405-413.
    [28]
    DE PASQUALE A, RUSSA G, PULVIRENTI M, et al. Hyaluronic acid filler injections for tear-trough deformity: injection technique and high-frequency ultrasound follow-up evaluation[J]. Aesthetic Plast Surg, 2013, 37(3): 587-591.
    [29]
    PARK T H, SEO S W, KIM J K, et al. Clinical experience with hyaluronic acid-filler complications[J]. J Plast Reconstr Aesthet Surg, 2011, 64(7): 892-896.
    [30]
    吴艳. 透明质酸面部填充不良反应的预防与治疗专家共识[J]. 临床皮肤科杂志, 2019, 48(8): 518-521.
    [31]
    ARTZI O, COHEN J L, DOVER J S, et al. Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm[J]. Clin Cosmet Investig Dermatol, 2020, 13: 371-378.
    [32]
    BELEZNAY K, CARRUTHERS J D A, CARRUTHERS A, et al. Delayed-onset nodules secondary to a smooth cohesive 20 mg/mL hyaluronic acid filler: cause and management[J]. Dermatol Surg, 2015, 41(8): 929-939.
    [33]
    OWCZARCZYK-SACZONEK A, ZDANOWSKA N, WYGONOWSKA E, et al. The immunogenicity of hyaluronic fillers and its consequences[J]. Clin Cosmet Investig Dermatol, 2021, 14: 921-934.
    [34]
    SADASHIVAIAH A B, MYSORE V. Biofilms: their role in dermal fillers[J]. J Cutan Aesthet Surg, 2010, 3(1): 20-22.
    [35]
    CHIANG Y Z, PIERONE G, AL-NIAIMI F. Dermal fillers: pathophysiology, prevention and treatment of complications[J]. J Eur Acad Dermatol Venereol, 2017, 31(3): 405-413.
    [36]
    WOODWARD J, KHAN T, MARTIN J. Facial filler complications[J]. Facial Plast Surg Clin N Am, 2015, 23(4): 447-458.
    [37]
    ARTZI O, COHEN J L, DOVER J S, et al. Delayed inflammatory reactions to hyaluronic acid fillers: a literature review and proposed treatment algorithm[J]. Clin Cosmet Investig Dermatol, 2020, 13: 371-378.
    [38]
    OWCZARCZYK-SACZONEK A, ZDANOWSKA N, WYGONOWSKA E, et al. The immunogenicity of hyaluronic fillers and its consequences[J]. Clin Cosmet Investig Dermatol, 2021, 14: 921-934.
    [39]
    王艺霏, 李延, 陶娟, 透明质酸面颈部及手背填充引发迟发性肉芽肿1例[J]. 中国医疗美容, 2012, 12(2): 10-11.
    [40]
    ROHRICH R J, BARTLETT E L, DAYAN E. Practical approach and safety of hyaluronic acid fillers[J]. Plast Reconstr Surg Glob Open, 2019, 7(6): e2172.
    [41]
    ALIJOTAS-REIG J, FERNÉNDEZ-FIGUERAS M T, PUIG L. Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers[J]. Semin Arthritis Rheum, 2013, 43(2): 241-258.
    [42]
    MUNAVALLI G G, GUTHRIDGE R, KNUTSEN-LARSON S, et al. "COVID-19/SARS-CoV-2 virus spike protein-related delayed inflammatory reaction to hyaluronic acid dermal fillers: a challenging clinical conundrum in diagnosis and treatment"[J]. Arch Dermatol Res, 2022, 314(1): 1-15.
    [43]
    DECATES T S, VELTHUIS P J, SCHELKE L W, et al. Increased risk of late-onset, immune-mediated, adverse reactions related to dermal fillers in patients bearing HLA-B*08 and DRB1*03 haplotypes[J]. Dermatol Ther, 2021, 34(1): e14644.
    [44]
    HUMPHREY S, JONES D H, CARRUTHERS J D, et al. Retrospective review of delayed adverse events secondary to treatment with a smooth, cohesive 20 mg/mL hyaluronic acid filler in 4 500 patients[J]. J Am Acad Dermatol, 2020, 83(1): 86-95.
    [45]
    FUNT D, PAVICIC T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches[J]. Clin Cosmet Investig Dermatol, 2013, 6: 295-316.
    [46]
    BAILEY S H, COHEN J L, KENKEL J M. Etiology, prevention, and treatment of dermal filler complications[J]. Aesthet Surg J, 2011, 31(1): 110-121.
    [47]
    TEO A A, MOKHTARZADEH A, DOUGLAS CAMERON J, et al. Late presentation of enlarging lower eyelid mass and muscle degeneration secondary to hyaluronic acid filler[J]. Ophthalmic Plast Reconstr Surg, 2017, 33(3S Suppl 1): S9-S11.
    [48]
    MUSTAK H, FIASCHETTI D, GOLDBERG R A. Filling the periorbital hollows with hyaluronic acid gel: Long-term review of outcomes and complications[J]. J Cosmet Dermatol, 2018, 17(4): 611-616.
    [49]
    DAYAN S H, ARKINS J P, SOMENEK M. Restylane persisting in lower eyelids for 5 years[J]. J Cosmet Dermatol, 2012, 11(3): 237-238.
    [50]
    IVERSON S M, PATEL R M. Dermal filler-associated malar edema: treatment of a persistent adverse effect[J]. Orbit, 2017, 36(6): 473-475.
    [51]
    BELEZNAY K, CARRUTHERS J D A, HUMPHREY S, et al. Avoiding and treating blindness from fillers: a review of the world literature[J]. Dermatol Surg, 2015, 41(10): 1097-1117.
    [52]
    OZTURK C N, LI Y M, TUNG R, et al. Complications following injection of soft-tissue fillers[J]. Aesthet Surg J, 2013, 33(6): 862-877.
    [53]
    DAINES S M, WILLIAMS E F. Complications associated with injectable soft-tissue fillers: a 5-year retrospective review[J]. JAMA Facial Plast Surg, 2013, 15(3): 226-231.
    [54]
    BELEZNAY K, HUMPHREY S, CARRUTHERS J D A, et al. Vascular compromise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes[J]. 2014, 7(9): 37-43.
    [55]
    KIM D W, YOON E S, JI Y H, et al. Vascular complications of hyaluronic acid fillers and the role of hyaluronidase in management[J]. J Plast Reconstr Aesthet Surg, 2011, 64(12): 1590-1595.
    [56]
    ROBERTS S A I, ARTHURS B P. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection[J]. Ophthalmic Plast Reconstr Surg, 2012, 28(3): e68-70.
    [57]
    KWON S G, HONG J W, ROH T S, et al. Ischemic oculomotor nerve palsy and skin necrosis caused by vascular embolization after hyaluronic acid filler injection: a case report[J]. Ann Plast Surg, 2013, 71(4): 333-334.
    [58]
    KIM S N, BYUN D S, PARK J H, et al. Panophthalmoplegia and vision loss after cosmetic nasal dorsum injection[J]. J Clin Neurosci, 2014, 21(4): 678-680.
    [59]
    WIBOWO A, KAPOOR K M, PHILIPP-DORMSTON W G. Reversal of post-filler vision loss and skin ischaemia with high-dose pulsed hyaluronidase injections[J]. Aesthetic Plast Surg, 2019, 43(5): 1337-1344.
    [60]
    HWANG C J, MORGAN P V, PIMENTEL A, et al. Rethinking the role of nitroglycerin ointment in ischemic vascular filler complications: an animal model with ICG imaging[J]. Ophthalmic Plast Reconstr Surg, 2016, 32(2): 118-122.
    [61]
    MOUSAVI S, MORADI M, KHORSHIDAHMAD T, et al. Anti-inflammatory effects of heparin and its derivatives: a systematic review[J]. Adv Pharmacol Sci, 2015, 2015: 507151.
    • Related Articles

  • Related Articles

    [1]WANG Jingjing, WU Su, CAI Guilan, ZHEN Yong. Construction and application of a risk prediction model for lower limb deep vein thrombosis in patients with aneurysmal subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2024, 28(19): 95-99, 104. DOI: 10.7619/jcmp.20241629
    [2]GU Yuchen, LIANG Ruofei, TANG Xiaoping. Bibliometric analysis of cognitive dysfunction after aneurysmal subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2024, 28(19): 33-40. DOI: 10.7619/jcmp.20241397
    [3]LI Jun, DING Lianshu. Microsurgical clipping versus endovascular embolization in treating delayed cerebral ischemia after rupture of middle cerebral artery aneurysm[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 1-5, 15. DOI: 10.7619/jcmp.20231167
    [4]YU Xiaochen, Yimamu YIDAYITULA, CAI Ning, ZHANG Yonghui. Dynamic changes of serum neuron-specific enolase in patients with single traumatic subarachnoid hemorrhage and its value in predicting prognosis[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 8-12. DOI: 10.7619/jcmp.20201422
    [5]PEI Shuang, WEN Changming. Effect of alprostadil combined with nimodipine on inflammatory factors in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2020, 24(17): 83-85. DOI: 10.7619/jcmp.202017022
    [6]ZHANG Zhen, ZHANG Hengzhu, LI Yuping, YAN Zhengcun, DONG Lun, WANG Xiaodong, WANG Xingdong. Relationship between systemic inflammation response index and symptomatic cerebral vasospasm after aneurismal subarachnoid hemorrhage as well as construction of a Nomogram predictive model[J]. Journal of Clinical Medicine in Practice, 2020, 24(10): 36-40. DOI: 10.7619/jcmp.202010009
    [7]WU Mingqin, ZHANG Luoluo, LIU Guoping. Application of standardized pain management in patients with spontaneous subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2019, 23(20): 120-122. DOI: 10.7619/jcmp.201920033
    [8]MA Liujia, CHAI Lei. Effect observation of nimodipine combined with edaravone in treatment of cerebral vasospasm after subarachnoid hemorrhage[J]. Journal of Clinical Medicine in Practice, 2019, 23(17): 52-54, 64. DOI: 10.7619/jcmp.201917015
    [9]REN Li, XING Jin, WEI Zilong, WANG Zhihan, ZHAO Liang, QIU Yongming, LIN Yingying. Significance of expressions of glutamate transporters and γ-aminobutyric acid transporters in rat model with cerebral ischemia[J]. Journal of Clinical Medicine in Practice, 2017, (3): 48-51. DOI: 10.7619/jcmp.201703015
    [10]GUAN Ping, LI Ronghua, YANG Xiaohua. Effect of consecutive lumbar puncture on aneurysmal subarachnoid hemorrhage after embolization[J]. Journal of Clinical Medicine in Practice, 2014, (24): 16-18. DOI: 10.7619/jcmp.201424005

  • Cited by

    Periodical cited type(4)

    1. 李丽芳，杨中男，刘力源，关郑军，徐艳，贺红丽，李燕萍. LncRNA LIPCAR在慢性心力衰竭患者外周血中的表达及临床意义. 宁夏医学杂志. 2024(09): 758-761 .
    2. 朱占占，孙雯雯，张申伟. 二甲双胍联合达格列净治疗2型糖尿病合并射血分数中间值心力衰竭患者的效果. 河南医学研究. 2022(21): 3980-3983 .
    3. 柳湘洁，刘晓霞. 沙库巴曲缬沙坦对射血分数中间值心力衰竭患者心功能及近期预后的影响. 临床和实验医学杂志. 2021(16): 1689-1692 .
    4. 左路广，黄冠杰，詹明华，李宝亮，张斌. 慢性心力衰竭并发感染患者病原学及脑钠肽变化研究. 实用临床医药杂志. 2021(19): 49-52 . 本站查看

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (38) PDF downloads (26) Cited by(5)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return